🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 12 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/10/2021 101,56 102,92 101,16 101,88 +0,61% 1,73% 536.900
27/10/2021 101,61 102,37 100,51 101,26 -0,57% 1,83% 338.400
26/10/2021 103,04 103,58 101,52 101,84 -0,69% 2,00% 534.900
25/10/2021 103,14 104,23 102,33 102,55 -0,96% 1,84% 656.900
22/10/2021 104,34 104,34 102,25 103,54 -0,44% 2,00% 634.900
21/10/2021 103,92 104,41 103,16 104,00 +0,61% 1,20% 665.000
20/10/2021 103,65 104,50 102,81 103,37 +0,23% 1,63% 669.400
19/10/2021 104,88 105,25 102,73 103,13 -0,86% 2,40% 492.000
18/10/2021 104,47 104,97 102,94 104,02 -0,50% 1,94% 438.200
15/10/2021 103,08 106,08 101,88 104,54 +1,86% 4,07% 911.200
14/10/2021 101,94 103,92 101,39 102,63 -0,98% 2,48% 624.600
13/10/2021 104,34 104,93 102,29 103,65 -1,15% 2,53% 394.700
12/10/2021 104,14 107,11 104,14 104,86 +1,00% 2,85% 566.800
11/10/2021 104,43 104,47 103,33 103,82 -0,25% 1,09% 378.000
08/10/2021 103,04 104,54 101,60 104,08 +1,01% 2,85% 400.800
07/10/2021 102,33 105,25 102,22 103,04 +0,56% 2,96% 585.700
06/10/2021 99,24 103,92 99,21 102,47 +2,29% 4,75% 589.500
05/10/2021 100,36 101,51 99,48 100,18 -0,62% 2,02% 458.600
04/10/2021 101,73 102,80 100,49 100,80 -0,65% 2,27% 587.500
01/10/2021 95,36 102,03 95,36 101,46 +5,79% 6,99% 860.100
30/09/2021 94,72 96,98 94,24 95,91 +1,61% 2,89% 477.300
29/09/2021 95,23 95,99 94,21 94,39 -0,92% 1,87% 459.900
28/09/2021 94,16 96,94 93,61 95,27 +0,38% 3,54% 521.900
27/09/2021 95,01 96,98 94,37 94,91 -0,08% 2,75% 432.100
24/09/2021 94,40 97,26 94,40 94,99 -0,06% 3,03% 394.300
23/09/2021 94,28 95,54 93,51 95,05 +0,83% 2,15% 406.100
22/09/2021 95,30 95,83 93,94 94,27 -1,30% 1,98% 382.000
21/09/2021 95,69 96,15 94,95 95,51 +0,25% 1,25% 448.100
20/09/2021 94,87 96,12 94,11 95,27 -1,27% 2,12% 624.200
17/09/2021 95,55 96,99 94,15 96,50 +0,81% 2,97% 1.529.900